|
Activity Number:
|
430
|
|
Type:
|
Luncheons
|
|
Date/Time:
|
Wednesday, August 9, 2006 : 12:30 PM to 1:50 PM
|
|
Sponsor:
|
Biopharmaceutical Section
|
| Abstract - #305438 |
|
Title:
|
Translational Medicine: from R to D and from D to R
|
|
Author(s):
|
Chi-Hse Teng*+ and Patricia English
|
|
Companies:
|
Pfizer Inc. and Pfizer Inc.
|
|
Address:
|
Science Center Drive, San Diego, CA, 92121,
|
|
Keywords:
|
translational medicine ; translational research ; genomics ; biomarkers
|
|
Abstract:
|
The pharmaceutical industry is facing enormous pressure to increase productivity. One approach taken commonly by pharmaceutical companies is to implement translational medicine to bridge the gap between discovery and clinical development. Translational medicine has been characterized as a "two-way road: bench to bedside and bedside to bench," (Marincola 2003) "from accurate diagnosis to appropriate treatment" (Webb 2004). This luncheon is intended to provide a place for statisticians interested and/or working in this area to discuss opportunities, share their experiences, and map out necessary steps for statisticians to work in this area.
|
